Mengke Qu

930 total citations · 1 hit paper
10 papers, 792 citations indexed

About

Mengke Qu is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Mengke Qu has authored 10 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Biomaterials and 3 papers in Biomedical Engineering. Recurrent topics in Mengke Qu's work include Nanoparticle-Based Drug Delivery (3 papers), RNA Interference and Gene Delivery (3 papers) and Extracellular vesicles in disease (2 papers). Mengke Qu is often cited by papers focused on Nanoparticle-Based Drug Delivery (3 papers), RNA Interference and Gene Delivery (3 papers) and Extracellular vesicles in disease (2 papers). Mengke Qu collaborates with scholars based in China, Sweden and United Kingdom. Mengke Qu's co-authors include Qing Lin, Zhirong Zhang, Ling Zhang, Shanshan He, Yao Fu, Yu Fu, Xun Sun, Luyao Wang, Luyi Huang and Shengyong Yang and has published in prestigious journals such as Advanced Functional Materials, Journal of Controlled Release and Nanoscale.

In The Last Decade

Mengke Qu

10 papers receiving 784 citations

Hit Papers

Dopamine-loaded blood exosomes targeted to brain for bett... 2018 2026 2020 2023 2018 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengke Qu China 9 593 266 140 130 66 10 792
Ruichen Zhao China 13 491 0.8× 179 0.7× 137 1.0× 127 1.0× 103 1.6× 27 818
Kandarp M. Dave United States 12 393 0.7× 138 0.5× 71 0.5× 75 0.6× 62 0.9× 17 586
Edison Salas‐Huenuleo Chile 12 419 0.7× 127 0.5× 187 1.3× 164 1.3× 91 1.4× 17 808
Jungju Oh South Korea 14 424 0.7× 86 0.3× 84 0.6× 76 0.6× 28 0.4× 19 599
Guangtian Wang China 11 393 0.7× 195 0.7× 198 1.4× 155 1.2× 40 0.6× 25 719
Ilaria Penna Italy 14 337 0.6× 158 0.6× 113 0.8× 43 0.3× 22 0.3× 21 674
Urarika Luesakul Thailand 9 378 0.6× 160 0.6× 188 1.3× 198 1.5× 64 1.0× 9 940
Bo Fan China 18 351 0.6× 100 0.4× 169 1.2× 212 1.6× 62 0.9× 36 806
Gülşah Çeçener Türkiye 19 630 1.1× 372 1.4× 109 0.8× 62 0.5× 15 0.2× 108 1.1k
Boyan Li China 19 631 1.1× 283 1.1× 72 0.5× 194 1.5× 21 0.3× 47 1.1k

Countries citing papers authored by Mengke Qu

Since Specialization
Citations

This map shows the geographic impact of Mengke Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengke Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengke Qu more than expected).

Fields of papers citing papers by Mengke Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengke Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengke Qu. The network helps show where Mengke Qu may publish in the future.

Co-authorship network of co-authors of Mengke Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Mengke Qu. A scholar is included among the top collaborators of Mengke Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengke Qu. Mengke Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Lin, Qing, Mengke Qu, Bingjie Zhou, et al.. (2019). Exosome-like nanoplatform modified with targeting ligand improves anti-cancer and anti-inflammation effects of imperialine. Journal of Controlled Release. 311-312. 104–116. 78 indexed citations
2.
Lin, Qing, Mengke Qu, Hirak K. Patra, et al.. (2019). Mechanistic and therapeutic study of novel anti-tumor function of natural compound imperialine for treating non-small cell lung cancer. Journal of Ethnopharmacology. 247. 112283–112283. 26 indexed citations
3.
Wang, Luyao, Bingjie Zhou, Shiqi Huang, et al.. (2019). Novel fibronectin-targeted nanodisk drug delivery system displayed superior efficacy against prostate cancer compared with nanospheres. Nano Research. 12(10). 2451–2459. 18 indexed citations
4.
Qu, Mengke, Qing Lin, Luyi Huang, et al.. (2018). Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease. Journal of Controlled Release. 287. 156–166. 446 indexed citations breakdown →
5.
Fu, Yu, Biyue Zhu, Mengke Qu, et al.. (2018). Insulin Delivery: Erythrocyte‐Membrane‐Camouflaged Nanoplatform for Intravenous Glucose‐Responsive Insulin Delivery (Adv. Funct. Mater. 41/2018). Advanced Functional Materials. 28(41). 3 indexed citations
6.
Qu, Mengke, Qing Lin, Shanshan He, et al.. (2018). A brain targeting functionalized liposomes of the dopamine derivative N -3,4-bis(pivaloyloxy)-dopamine for treatment of Parkinson's disease. Journal of Controlled Release. 277. 173–182. 99 indexed citations
7.
Wang, Luyao, Mengke Qu, Yu Fu, et al.. (2018). A novel α-enolase-targeted drug delivery system for high efficacy prostate cancer therapy. Nanoscale. 10(28). 13673–13683. 32 indexed citations
8.
He, Shanshan, Qing Lin, Mengke Qu, et al.. (2018). Liver-Targeted Co-delivery of Entecavir and Glycyrrhetinic Acid Based on Albumin Nanoparticle To Enhance the Accumulation of Entecavir. Molecular Pharmaceutics. 15(9). 3953–3961. 19 indexed citations
9.
Fu, Yu, Biyue Zhu, Mengke Qu, et al.. (2018). Erythrocyte‐Membrane‐Camouflaged Nanoplatform for Intravenous Glucose‐Responsive Insulin Delivery. Advanced Functional Materials. 28(41). 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026